[The council for new therapies position on eculizumab is unacceptable]

Lakartidningen. 2015 Jun 9:112:DI3F.
[Article in Swedish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized* / economics
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Atypical Hemolytic Uremic Syndrome / drug therapy*
  • Child
  • Humans
  • Practice Guidelines as Topic / standards*
  • Sweden

Substances

  • Antibodies, Monoclonal, Humanized
  • eculizumab